Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00011765Phase 2Completed
Phase 2, randomised, double-blind trial comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Aggression (measured by rating scales and paradigms) at 12 weeks. Started Feb 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00011765.